<Australia - October 13, 2022> To mark its 21st anniversary of pioneering bone health in Australia today, Healthy Bones Australia has announced its strategic partnership with CurveBeam AI to develop a breakthrough diagnostic fracture prediction tool. Since its inception, the…
The benefits of using weight bearing CT (WBCT) imaging for pre-operative planning have been explored in-depth in recent peer-reviewed scientific publications. However, users of this low dose modality have found it useful for post-operative assessment of fracture healing as well.…
Key Points: The Kellgren Lawrence (KL) grade is the most common system used to classify osteoarthritis (OA) severity, but it is a subjective evaluation with fair or poor reliability. Researchers described a new method of quantifying ankle osteoarthritis (OA) by…
CurveBeam AI Medical Director - Endocrinology Prof. Ego Seeman recently sat down with Vinti Singh, CurveBeam AI’s Marketing Director, to discuss the future of bone health imaging. Prof. Seeman is a Professor and Endocrinologist in the Departments of Medicine and…
CurveBeam AI Medical Director – Endocrinology Ego Seeman was awarded the Gideon A. Rodan Excellence in Mentorship Award at The American Society for Bone and Mineral Research (ASBMR) 2022 Annual Meeting in Austin, Texas earlier this month. Ego Seeman is…
<HATFIELD, Penn. - September 12, 2022> CurveBeam AI, Ltd announced its medical diagnostic software, OssView™, has received US Food and Drug Administration (FDA) Breakthrough Device Designation. OssView calculates a Structural Fragility Score (SFS), which determines bone microstructural deterioration, a highly…
Click above link to access a recording of a press conference with CEO Greg Brown and COO, CTO (CT), & President (US Division) Arun Singh
<Hatfield, Penn. – September 6, 2022> – CurveBeam, LLC of Hatfield PA, USA and StraxCorp Pty Ltd of Melbourne VIC, Australia announced they have entered into a definitive merger agreement to form CurveBeam AI Limited. CurveBeam AI expands CurveBeam’s financially viable…
